Cancer vaccines in development
By BC Staff | May 29, 2006 | 7:00 AM GMT
Cancer vaccines in development
| Company | Product | Description | Indication | Status |
| Avax/Pro Vaccine/Australian Vaccine Tech | M-Vax | Autologous haptenized tumor cell vaccine | Stage III and IV melanoma | Compassionate use in France, Spain and Belgium; Ph I/II in U.S. (start Ph III 1H06) |
| Biomira/ Merck KGaA | Stimuvax (BLP25) liposome vaccine | Liposomal vaccine containing a synthetic 25 amino acid peptide sequence from MUC-1 | Non-small cell lung cancer (NSCLC) | Ph IIb compl (start Ph III in mid-06) |
| Intracel | OncoVax | Autologous tumor cells combined with bacille Calmette-Guerin (BCG) | Stage II colon cancer | Start Ph III
|
Read the full 893 word article
